Entering text into the input field will update the search result below

Diplomat Pharmacy on deck for IPO

Sep. 30, 2014 1:34 PM ETIBB, BIB, BISBy: Douglas W. House, SA News Editor
  • Flint, Michigan-based Diplomat Pharmacy (DPLO) is set for its IPO of 13.3M shares at $14 - 16.
  • The company is the U.S.'s largest independent specialty pharmacy, founded in 1975. It focuses on specialty drugs that are typically administered on a recurring basis to treat patients with complex chronic diseases that require specialized handling and administration as part of their distribution process. It provides customized solutions for patients with cancer, MS, HIV, hepatitis, and other diseases as well as specialty infusion therapies for conditions like chronic genetic disorders (primarily hemophilia and immune globulin treatment).
  • 2013 financials: Revenues: $1.6B (+44.3%); Gross Profit: $112.6M (+62.5%); Operating Income: $12.0M (+144.9%); EPS: $0.14; CF Ops: $6.2M (+24.4%).
  • 1H 2014 financials: Revenues: $1.1B (+49.2%); Gross Profit: $67.1M (+65.3%); Operating Income: $9.3M (+99.8%); EPS: $0.11; CF Ops: $20.8M (+999%).
  • S-1
  • ETFs: IBB, BIB, BIS

Recommended For You

More Trending News